person · Reporting owner
Hollingsworth Jarvis V.
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CULLEN/FROST BANKERS, INC.CFR · Entity 3533 | Director | April 24, 2019 | April 25, 2019 |
| Crescent Energy CoCRGY · Entity 3846 | Director | April 01, 2026 | April 02, 2026 |
| Kayne DL 2021, Inc.None · Entity 76473 | Director · Secretary | May 11, 2021 | May 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CULLEN/FROST BANKERS, INC.
Report date April 24, 2019 · Filed April 25, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,132 |
Reported balance
After 2019-04-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-04-24 · Grant · Acquired 584 · Balance 1,132 F1: Each deferred stock unit represents the right to receive one share of Cullen/Frost Bankers, Inc. common stock. F2: The deferred stock units vested on April 24, 2019. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Cullen/Frost Bankers, Inc. common stock.
F2: The deferred stock units vested on April 24, 2019. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc.
Crescent Energy Co
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 55,656 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 17,411 · Balance 55,656 F1: The shares of Crescent Energy Company (the "Issuer") Class A common stock ("Common Stock") reported are restricted stock units ("RSUs") granted to the reporting person pursuant to the Crescent Energy Company 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on April 1, 2027, subject to the reporting person's continuous service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Crescent Energy Company (the "Issuer") Class A common stock ("Common Stock") reported are restricted stock units ("RSUs") granted to the reporting person pursuant to the Crescent Energy Company 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on April 1, 2027, subject to the reporting person's continuous service through such date.
Kayne DL 2021, Inc.
Report date May 11, 2021 · Filed May 12, 2021
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Core Scientific, Inc./tx
Report date January 23, 2024 · Filed February 16, 2024 · Amendment
Section 16 reporting ended · disclosed 2024-02-16. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-23 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2024-01-23 · Disposition to issuer · Disposed 1,211,956 · Balance 0 F1: On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. |
| Common Stock, par value $0.00001 per shareSEC Table I · non-derivative | Direct | 121,196 |
Reported balance
After 2024-01-23 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2024-01-23 · Grant · Acquired 121,196 · Balance 121,196 F2: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. |
| Tranche 1 WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $6.81 · Expires 2027-01-23 | Direct | 256,267 |
Reported balance
After 2024-01-23 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2024-01-23 · Grant · Acquired 256,267 · Balance 256,267 F2: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. |
| Tranche 2 WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2029-01-23 | Direct | 213,556 |
Reported balance
After 2024-01-23 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2024-01-23 · Grant · Acquired 213,556 · Balance 213,556 F2: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.
F2: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below).
F3: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.
F4: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price").
F5: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement.
Vital Energy, Inc.
Report date December 15, 2025 · Filed December 15, 2025
Section 16 reporting ended · disclosed 2025-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-12-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-15 · Exercise / conversion · Acquired 11,317 · Balance 20,064 F1: On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent. F2: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). Row 2 · 2025-12-15 · Disposition to issuer · Disposed 20,064 · Balance 0 F1: On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent. F2: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-12-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-15 · Exercise / conversion · Disposed 11,317 · Balance 0 F2: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). |
Filing footnotes · ownership attribution and instrument terms
F1: On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent.
F2: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 20:40 UTC | Crescent Energy Co CRGY · Entity 3846 | GrantClass A Common Stock | 17,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001866175-26-000056 · wk-form4_1775162397.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,656 F1 · price: The shares of Crescent Energy Company (the "Issuer") Class A common stock ("Common Stock") reported are restricted stock units ("RSUs") granted to the reporting person pursuant to the Crescent Energy Company 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on April 1, 2027, subject to the reporting person's continuous service through such date. Read SEC document |
| December 15, 2025 Filed Dec 15, 2025 16:47 UTC | Vital Energy, Inc. VTLE · Entity 71532 | Exercise / conversionDeferred Stock Units · Derivative | 11,317 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-319324 · ownership.xml · derivative · entry 3 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,317 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). F2 · price: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). F2 · derivative.exercise_date: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). F2 · derivative.expiration_date: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). Read SEC document |
| December 15, 2025 Filed Dec 15, 2025 16:47 UTC | Vital Energy, Inc. VTLE · Entity 71532 | Disposition to issuerCommon Stock | 20,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-319324 · ownership.xml · nonDerivative · entry 2 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent. F2 · price: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). Read SEC document |
| December 15, 2025 Filed Dec 15, 2025 16:47 UTC | Vital Energy, Inc. VTLE · Entity 71532 | Exercise / conversionCommon Stock | 11,317 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-319324 · ownership.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent. F2 · price: Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date). Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 16:58 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 2,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-25-000165 · wk-form4_1762984699.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,317 Underlying: Common Stock · 2,617 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 17:38 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 2,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-25-000126 · wk-form4_1754084297.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,700 Underlying: Common Stock · 2,141 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| May 22, 2025 Filed May 27, 2025 16:45 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 2,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-25-000088 · wk-form4_1748378746.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,559 Underlying: Common Stock · 2,651 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 16:27 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 1,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-25-000018 · wk-form4_1738963672.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,823 Underlying: Common Stock · 1,270 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| February 06, 2025 Filed Mar 13, 2025 16:43 UTC Amendment | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 1,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-25-000059 · wk-form4a_1741898625.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,908 Underlying: Common Stock · 1,270 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F3 · balance_after: The Form 4 as originally filed incorrectly reported the number of derivative securities beneficially owned. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 19:48 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantCommon Stock | 1,467 | $27.27 | $40,005.09 |
DisclosureSEC source: 0001528129-24-000185 · wk-form4_1730767726.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,747 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 16:55 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantCommon Stock | 941 | $42.55 | $40,039.55 |
DisclosureSEC source: 0001528129-24-000143 · wk-form4_1722891317.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,280 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| May 23, 2024 Filed May 28, 2024 16:40 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantCommon Stock | 842 | $47.55 | $40,037.10 |
DisclosureSEC source: 0001528129-24-000123 · wk-form4_1716928803.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,339 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 18:18 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 915 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-24-000019 · wk-form4_1707520726.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,553 Underlying: Common Stock · 915 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| February 08, 2024 Filed Feb 15, 2024 17:07 UTC Amendment | Vital Energy, Inc. VTLE · Entity 71532 | GrantCommon Stock | 915 | $43.76 | $40,040.40 |
DisclosureSEC source: 0001528129-24-000032 · wk-form4a_1708034860.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,497 F1 · security: The Form 4 as originally filed incorrectly reported the shares as derivative securities when the shares were non-derivative securities. F2 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock, par value $0.00001 per share | 1,211,956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-007646 · ownership.xml · nonDerivative · entry 2 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,211,956 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share ("New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Disposition to issuerCommon Stock, par value $0.0001 per share | 1,211,956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-007646 · ownership.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share ("New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 16:22 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | GrantTranche 2 Warrants · Derivative | 213,556 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0000950170-24-016403 · ownership.xml · derivative · entry 4 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,556 Underlying: Common Stock, par value $0.00001 per share · 213,556 shares Expires 2029-01-23 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3 · price: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · price: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. F4 · derivative.exercise_date: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · derivative.exercise_date: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 16:22 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | GrantTranche 1 Warrants · Derivative | 256,267 | Not disclosed Strike: $6.81 | Not disclosed |
DisclosureSEC source: 0000950170-24-016403 · ownership.xml · derivative · entry 3 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,267 Underlying: Common Stock, par value $0.00001 per share · 256,267 shares Expires 2027-01-23 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3 · price: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. F4 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · price: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. F4 · derivative.exercise_date: On the Effective Date, pursuant to the terms of the Plan, the Issuer entered into a warrant agreement dated as of January 23, 2024, (the "Warrant Agreement") among the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company. Pursuant to the Warrant Agreement, the Issuer was authorized to issue (i) an aggregate of 98,381,418 warrants, each exercisable for one share of New Common Stock (the "Tranche 1 Warrants") and (ii) an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the "Tranche 2 Warrants"). Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share (the "Tranche 1 Exercise Price"). F5 · derivative.exercise_date: (Continued from footnote 4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the "TEV Triggering Event"). The Tranche 1 Exercise Price and the price per share used to determine a TEV Triggering Event are subject to certain adjustments as set forth in the Warrant Agreement. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 16:22 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock, par value $0.00001 per share | 121,196 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016403 · ownership.xml · nonDerivative · entry 2 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,196 F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3 · price: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| January 23, 2024 Filed Feb 16, 2024 16:22 UTC Amendment | Core Scientific, Inc./tx CORZ · Entity 389 | Disposition to issuerCommon Stock, par value $0.0001 per share | 1,211,956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016403 · ownership.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. F2 · price: On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock and unvested restricted stock units ("RSUs") received new common stock, par value $0.00001 per share at an exchange ratio of 10:1 (the "New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization), and, for each share of Old Common Stock, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants (each as defined below). F3 · price: (Continued from footnote 2) The receipt of the New Common Stock, Tranche 1 Warrants and Tranche 2 Warrants in exchange for Old Common Stock and unvested RSUs was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 18:37 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-23-000196 · wk-form4_1699051069.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,638 Underlying: Common Stock · 638 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 17:33 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 618 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-23-000154 · wk-form4_1691444006.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 618 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| May 25, 2023 Filed May 26, 2023 16:54 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-23-000115 · wf-form4_168513444704053.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,382 Underlying: Common Stock · 750 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| February 09, 2023 Filed Feb 10, 2023 17:41 UTC | Vital Energy, Inc. VTLE · Entity 71532 | GrantDeferred Stock Units · Derivative | 632 | $0.00 | $0.00 |
DisclosureSEC source: 0001528129-23-000029 · wf-form4_167606885694513.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632 Underlying: Common Stock · 632 shares Expires not disclosed F1 · derivative.exercise_price: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. F2 · derivative.exercise_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. F2 · derivative.expiration_date: These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 16:30 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 507 | $64.20 | $32,549.40 |
DisclosureSEC source: 0001528129-22-000204 · wf-form4_166880703418444.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 16:18 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 431 | $75.58 | $32,574.98 |
DisclosureSEC source: 0001528129-22-000159 · wf-form4_166119951896272.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,075 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| June 13, 2022 Filed Sep 6, 2022 18:30 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 400,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048848 · doc4.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,211,956 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in four equal annual installments commencing September 17, 2022, provided that the Reporting Person continues to provide service to the Issuer on each vesting date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 16:18 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 425 | $76.52 | $32,521.00 |
DisclosureSEC source: 0001528129-22-000101 · wf-form4_165402828476714.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,644 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 16:21 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 454 | $71.73 | $32,565.42 |
DisclosureSEC source: 0001528129-22-000025 · wf-form4_164521924371288.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,219 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 16:21 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 494 | $65.86 | $32,534.84 |
DisclosureSEC source: 0001528129-21-000202 · wf-form4_163735689665969.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,765 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 16:32 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 518 | $48.25 | $24,993.50 |
DisclosureSEC source: 0001528129-21-000149 · wf-form4_162871394937856.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,271 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 12:36 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 1,006 | $65.28 | $65,671.68 |
DisclosureSEC source: 0001528129-21-000102 · wf-form4_162273815941560.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,753 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 10:03 UTC | Vital Energy, Inc. LPI · Entity 71532 | GrantCommon Stock | 747 | $33.46 | $24,994.62 |
DisclosureSEC source: 0001528129-21-000048 · wf-form4_161461097309538.xml · nonDerivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747 F1 · shares: These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent payment of the director's retainer and director fees, which are paid 50% in stock and 50% in cash. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 17:27 UTC | CULLEN/FROST BANKERS, INC. CFR · Entity 3533 | GrantDeferred Stock Units · Derivative | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025908 · doc4.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132 Underlying: Common Stock · 584 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Cullen/Frost Bankers, Inc. common stock. F2 · derivative.exercise_date: The deferred stock units vested on April 24, 2019. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc. F2 · derivative.expiration_date: The deferred stock units vested on April 24, 2019. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 20:35 UTC | CULLEN/FROST BANKERS, INC. CFR · Entity 3533 | GrantDeferred Stock Units · Derivative | 548 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026237 · doc4.xml · derivative · entry 1 Hollingsworth Jarvis V. · CIK 0001737855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548 Underlying: Common Stock · 548 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Cullen/Frost Bankers, Inc. common stock. F2 · derivative.exercise_date: The deferred stock units vested on April 25, 2018. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc. F2 · derivative.expiration_date: The deferred stock units vested on April 25, 2018. Shares will be delivered to the reporting person on the date when the reporting person experiences a separation from service with Cullen/Frost Bankers, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.